Artelo Biosciences Inc. held a Special Meeting of Stockholders on August 28, 2025. During the meeting, several proposals were put forward for voting. An amendment to the Articles of Incorporation to increase the authorized number of shares of Common Stock from 8,333,333 to 500,000,000 was approved. However, a proposal to amend the Articles to increase the number of authorized shares of Preferred Stock from 69,444 to 10,000,000 and to authorize the issuance of these shares with rights and preferences determined by the Board of Directors was not approved. Additionally, the appointment of Malone Bailey LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artelo Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-25-001613), on August 29, 2025, and is solely responsible for the information contained therein.